Item 2.02   Results of Operations and Financial Condition.

On November 5, 2020, ANI Pharmaceuticals, Inc. ("ANI") issued a press release announcing its financial and operating results for the three and nine months ended September 30, 2020. A copy of the press release is furnished as Exhibit 99.1 to this report.

In accordance with General Instruction B.2. of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.




Item 9.01   Financial Statements and Exhibits.




(d) Exhibits



No.                                       Description

  99.1       Press release, dated November 5, 2020, issued by ANI

104        Cover Page Interactive Data File. The cover page XBRL tags are embedded
           within the inline XBRL document (contained in Exhibit 101).

© Edgar Online, source Glimpses